Table 5. Comparison between several Taiwan ACS registries.
TSOC ACS registry I | TSOC ACS registry II | TSGH-CHD ACS registry | |
Study period | 2008-2010 | 2012-2015 | 2014-2016 |
Study design | multi-center* | multi-center* | single-center |
Patient number (N) | 3183 | 2,357# | 1003 |
Baseline characteristics | |||
Age (years) | 63.1 ± 13.6 | 61.8 ± 12.8 | 63.9 ± 13.9 |
Women | 22.0% | 17.7% | 25.5% |
Hypertension | 64.0% | 63.7% | 67.6% |
Diabetes mellitus | 36.0% | 34.3% | 36.6% |
Dyslipidemia | 39.1% | 44.5% | 32.2% |
Prior myocardial infarction | 41.1% | 9.1% | 19.6% |
Prior heart failure | 5.4% | 5.5% | 13.3% |
Prior stroke | 9.0% | 6.1% | 10.7% |
Characteristics of ACS | |||
STEMI | 52.3% | 54.9% | 35.2% |
NSTEMI | 33.9% | 45.1% | 54.3% |
UA | 12.2% | 0% | 10.5% |
Left main lesion | 3.2% | NA | 10.5% |
Treatment modalities | |||
DES implantation | 24.9% | 50.9% | 63.1% |
CABG referral | 3.3% | 0.2% | 8.3% |
Clinical outcomes | |||
In-hospital mortality | 1.8% | NA | 7.5% |
In-hospital stroke | 0.4% | NA | 0.6% |
Major bleeding | 1.8% | NA | 2.0% |
* 39 hospitals in Taiwan participated in the TSOC ACS registry I and 24 hospitals participated in the TSOC ACS registry II. # In TSOC ACS registry II, only ACS patients who received PCI with stenting during hospitalization were included.
ACS, acute coronary syndrome; CABG, coronary artery bypass grafting; DES, drug-eluting stent; NA, not available; NSTEMI, non-ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction; TSOC, Taiwan Society of Cardiology; TSGH-CHD, Tri-Service General Hospital–Coronary Heart Disease; UA, unstable angina.